Prof. Dr Babette Simon, President of the University, has been appointed to the Scientific Advisory Board of the "German Consortium for Translational Cancer Research (DKTK)" - one of the six German centres for health research.
The international advisory board supports the DKTK in aligning and ensuring the continuous excellent quality of translational research programmes and research platforms.
The consortium is intended to make a significant contribution to advancing translational cancer research by pooling expertise and capacities in basic and clinical cancer research and leading it to international excellence. The closer linking of competences, disciplines and institutions is intended to bring research results into medical care more quickly so that patients can benefit directly from scientific progress.
In addition to Simon, ten other experts from Germany, Finland, France, Great Britain, Norway, Sweden, Switzerland, Spain and the USA are members of the committee.
Simon has been President of the University of Oldenburg since 2010. Among other things, she is a member of the Medical Committee of the German Council of Science and Humanities and Senator of the Helmholtz Association for the Research Field Health.
German Consortium for Translational Cancer Research
The consortium is an alliance between the German Cancer Research Center (DKFZ), including the National Centre for Tumour Diseases (NTC) in Heidelberg, and seven translational centres at the partner sites in Berlin, Dresden, Essen/Düsseldorf, Frankfurt/Mainz, Freiburg, Tübingen and Munich. It was established on the initiative of the Federal Ministry of Education and Research (BMBF), German Cancer Aid, the participating Federal States and the DKFZ.